Literature DB >> 25237657

Induction of contraception by intraepididymal sclerotherapy.

Hyoung Keun Park1, Sung Hyun Paick1, Hyeong Gon Kim1, Yong Soo Lho1, Sang Rak Bae2.   

Abstract

PURPOSE: The objective of the present study was to evaluate the efficacy of a sclerosing solution for inducing epididymal occlusion in male rats.
MATERIALS AND METHODS: Male Sprague-Dawley rats were divided into two groups: an injection group (n=20) and control group (n=20). Before injecting the sclerosing agent, seminal vesiculectomy and sperm identification using electrostimulation were performed in all of the rats. In the injection group, 0.2 mL of 0.1% sodium tetradecyl sulfate solution was injected into the epididymis. In the sham group, only the identification of the epididymis was performed. At 4 and 12 weeks after the injection, semen was collected by electrostimulation and evaluated to assess the contraceptive effect. Epididymis was evaluated by hematoxylin and eosin (H&E) staining.
RESULTS: After 4 and 12 weeks, semen collection was performed in the two groups. Sperms were not observed in the injection group, while there was no change in the sperms in the sham group. H&E staining showed the obstruction of epididymal tubules and an accumulation of inflammatory cells in the injection group.
CONCLUSIONS: This study showed that the sclerosing agent induced sterilization in male rats. This result suggests that the injection method can replace vasectomy as a contraceptive method. However, a further study of large animals and a clinical study are needed. Further, the long-term effectiveness of this method needs to be studied.

Entities:  

Keywords:  Contraception; Male; Rats; Sterilization

Year:  2014        PMID: 25237657      PMCID: PMC4166374          DOI: 10.5534/wjmh.2014.32.2.83

Source DB:  PubMed          Journal:  World J Mens Health        ISSN: 2287-4208            Impact factor:   5.400


  9 in total

Review 1.  Varicose veins and their management.

Authors:  Bruce Campbell
Journal:  BMJ       Date:  2006-08-05

2.  Intratesticular injection of a zinc-based solution as a contraceptive for dogs.

Authors:  Erika C S Oliveira; Maria Raquel Moura; Valdemiro A Silva; Christina A Peixoto; Karina L A Saraiva; Marcelo Jorge Cavalcanti de Sá; Robert H Douglas; Antônio de Pinho Marques
Journal:  Theriogenology       Date:  2007-06-07       Impact factor: 2.740

Review 3.  Sclerotherapy for the permanent eradication of varicose veins: theoretical and practical considerations.

Authors:  D Green
Journal:  J Am Acad Dermatol       Date:  1998-03       Impact factor: 11.527

Review 4.  Results from RCTs in Sclerotherapy: European Guidelines for Sclerotherapy in Chronic Venous Disorders*

Authors:  F Pannier; E Rabe
Journal:  Phlebology       Date:  2014-05-19       Impact factor: 1.740

5.  Intravasal application of BCG (Bacille Calmette Guerin) is not an effective method for control of fertility in the male: a preliminary report.

Authors:  S K Singh; E Rovan; J Frick
Journal:  Contraception       Date:  1993-03       Impact factor: 3.375

6.  Permanent contraception of dogs induced with intratesticular injection of a Zinc Gluconate-based solution.

Authors:  Erika C S Oliveira; Maria Raquel P Moura; Marcelo J C de Sá; Valdemiro A Silva; John P Kastelic; Robert H Douglas; Antônio P Marques
Journal:  Theriogenology       Date:  2011-12-20       Impact factor: 2.740

7.  Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest.

Authors:  Leyda E Bowes; Mitchel P Goldman
Journal:  Dermatol Surg       Date:  2002-01       Impact factor: 3.398

8.  Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins.

Authors:  Brian C Leach; Mitchel P Goldman
Journal:  Dermatol Surg       Date:  2003-06       Impact factor: 3.398

9.  Sterilization of dogs with intra-epididymal injection of zinc arginine.

Authors:  M S Fahim; M Wang; M F Sutcu; Z Fahim; R S Youngquist
Journal:  Contraception       Date:  1993-01       Impact factor: 3.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.